Superior anticancer efficacy of curcumin-loaded nanoparticles against lung cancer

Acta Biochimica et Biophysica Sinica

Volumn 45, Issue 8, 2013, Pages 634-640

  Yin, Haitao ^a,b   Zhang, Hao ^c   Liu, Baorui ^d  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b XUZHOU CENTRAL HOSPITAL   (China)

^c THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^d MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

curcumin; lung cancer; mPEG PCL; nanoparticle

Indexed keywords

EID: 84880945235     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmt063     Document Type: Article

References (30)

1. Rocks N, Bekaert S, Coia I, Paulissen G, Gueders M, Evrard B and Van Heugen JC, et al. Curcumin-cyclodextrin complexes potentiate gemcitabine effects in an orthotopic mouse model of lung cancer. Br J Cancer 2012, 107: 1083-1092.
2. Maheshwari RK, Singh AK, Gaddipati J and Srimal RC. Multiple biological activities of curcumin: a short review. Life Sci 2006, 78: 2081-2087.
3. Sintara K, Thong-Ngam D, Patumraj S and Klaikeaw N. Curcumin attenuates gastric cancer induced by N-methyl-N-nitrosourea and saturated sodium chloride in rats. J Biomed Biotechnol 2012, 2012: 915380.
4. Huang MT, Lou YR, Ma W, Newmark HL, Reuhl KR and Conney AH. Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice. Cancer Res 1994, 54: 5841-5847.
5. Dorai T, Dutcher JP, Dempster DWand Wiernik PH. Therapeutic potential of curcumin in prostate cancer2V: interference with the osteomimetic properties of hormone refractory C4-2B prostate cancer cells. Prostate 2004, 60: 1-17.
6. Duvoix A, Blasius R, Delhalle S, Schnekenburger M, Morceau F, Henry E and Dicato M. Chemopreventive and therapeutic effects of curcumin. Cancer Lett 2005, 223: 181-190.
7. Wang Z, Zhang Y, Banerjee S, Li Y and Sarkar FH. Notch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells. Cancer 2006, 106: 2503-2513.
8. Wang YJ, Pan MH, Cheng AL, Lin LI, Ho YS, Hsieh CY and Lin JK. Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal 1997, 15: 1867-1876.
9. Tonnesen HH, Masson M and Loftsson T. Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability. Int J Pharm 2002, 244: 127-135.
10. Shoba G, Joy D, Joseph T, Majeed M, Rajendran R and Srinivas PS. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med 1998, 64: 353-356.
11. Kataoka K, Harada A and Nagasaki Y. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Deliv Rev 2001, 47: 113-131.
12. LaVan DA, McGuire T and Langer R. Small-scale systems for in vivo drug delivery. Nat Biotechnol 2003, 21: 1184-1191.
13. Pridgen EM, Langer R and Farokhzad OC. Biodegradable, polymeric nanoparticle delivery systems for cancer therapy. Nanomedicine 2007, 2: 669-680.
14. Cheng J, Teply BA, Sherifi I, Luther G, Gu FX, Levy-Nissenbaum E and Radovic-Moreno AF, et al. Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. Biomaterials 2007, 28: 869-876.
15. Uhrich KE, Cannizzaro SM, Langer RS and Shakesheff KM. Polymeric systems for controlled drug release. Chem Rev 1999, 99: 3181-3198.
16. Herold DA, Keil K and Bruns DE. Oxidation of polyethylene glycol by alcohol dehydrogenase. Biochem Pharmacol 1989, 38: 73-76.
17. Li XL, Li RT, Qian X, Ding Y, Tu Y, Guo R and Hu Y, et al. Superior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate. Eur J Pharm Biopharm 2008, 70: 726-734.
18. Hu Y, Xie J, Tong Y and Wang C. Effect of PEG conformation and particle size on the cellular uptake efficiency of nanoparticles with the HepG2 cells. J Control Release 2007, 118: 7-17.
19. Kim JH, Kim YS, Park K, Kang E, Lee S, Nam HY and Kim K, et al. Self-assembled glycol chitosan nanoparticles for the sustained and prolonged delivery of antiangiogenic small peptide drugs in cancer therapy. Biomaterials 2008, 29: 1920-1930.
20. Liu L, Ni F, Zhang J, Jiang X, Lu X, Guo Z and Xu R. Silver nanocrystals sensitize magnetic-nanoparticle-mediated thermo-induced killing of cancer cells. Acta Biochim Biophys Sin 2011, 43: 316-323.
21. Zhao D, Sun X, Tong J, Ma J, Bu X, Xu R and Fan R. A novel multifunctional nanocomposite C225-conjugated Fe3O4/Ag enhances the sensitivity of nasopharyngeal carcinoma cells to radiotherapy. Acta Biochim Biophys Sin 2012, 44: 678-684.
22. Davda J and Labhasetwar V. Characterization of nanoparticle uptake by endothelial cells. Int J Pharm 2002, 233: 51-59.
23. Rosen H and Abribat T. The rise and rise of drug delivery. Nat Rev Drug Discov 2005, 4: 381-385.
24. Li XL, Zhen DH, Lu XW, Xu H, Shao Y, Xue QP and Hu Y, et al. Enhanced cytotoxicity and activation of ROS-dependent c-Jun NH2-terminal kinase and caspase-3 by low doses of tetrandrine-loaded nanoparticles in Lovo cells-a possible Trojan strategy against cancer. Eur J Pharm Biopharm 2010, 75: 334-340.
25. Van VLE, Duan ZF, Seiden MV and Amiji MM. Modulation of intracellular ceramide using polymeric nanoparticles to overcome multidrug resistance in cancer. Cancer Res 2007, 67: 4843-4850.
26. Zhang L, Yang M, Wang Q, Li Y, Guo R, Jiang X and Yang C, et al. 10-Hydroxycamptothecin loaded nanoparticles: preparation and antitumor activity in mice. J Control Release 2007, 119: 153-162.
27. Zhang L, Hu Y, Jiang X, Yang C, Lu W and Yang Y. Camptothecin derivative-loaded poly(caprolactone-co-lactide)-b-PEG-b-poly(capro-lactone-co- lactide) nanoparticles and their biodistribution in mice. J Control Release 2004, 96: 135-148.
28. Shenoy D, Little S, Langer R and Amiji M. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumortargeted delivery of hydrophobic drugs. 1. In vitro evaluations. Mol Pharm 2005, 2: 357-366.
29. Rechsteiner M and Rogers SW. PEST sequences and regulation by proteolysis. Trends Biochem Sci 1996, 21: 267-271.
30. Wyllie AH, Kerr JF and Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol 1980, 68: 251-306.